Call For Papers
The ICPHAPM aims to explore emerging trends and future directions in research and innovation. It provides a collaborative platform for researchers and professionals to share ideas that shape the future of their respective domains.
The conference highlights advancements in Genetics, encouraging innovative, solution-oriented research that addresses global challenges and technological evolution.
Authors are invited to submit papers addressing, but not limited to, the following areas:
- Pharmacogenomics in drug development
- Personalized medicine and patient outcomes
- Genetic variants affecting drug metabolism
- Ethical considerations in pharmacogenomics
- Role of biomarkers in personalized therapy
- Clinical applications of pharmacogenomics
- Pharmacogenomics in oncology treatments
- Integration of genomics in clinical practice
- Challenges in implementing pharmacogenomics
- Pharmacogenomics and adverse drug reactions
- Impact of pharmacogenomics on healthcare costs
- Future of personalized medicine strategies
- Patient education in pharmacogenomics
- Pharmacogenomics in chronic disease management
- Collaborative approaches in pharmacogenomics research
- Regulatory frameworks for pharmacogenomic testing
- Pharmacogenomics and drug interactions
- Emerging technologies in pharmacogenomics
- Global perspectives on pharmacogenomics
- Translational research in pharmacogenomics
Assessment
Submissions will be assessed for originality, innovation, and relevance. Accepted papers will be presented at the conference and considered for publication opportunities in reputed academic platforms.
Registration
Participants are requested to complete the registration process following acceptance of their paper. Registration ensures inclusion in the conference schedule and official records.
Publication
All accepted manuscripts will be eligible for publication consideration in conference proceedings and associated academic journals.